MITRAL VALVE DYSPLASIA TREATMENT

Rajabova N. T.; Kilicheva T. A.

MITRAL VALVE DYSPLASIA TREATMENT

Authors

Rajabova N. T. PhD, Senior Lecturer, Department of Pediatrics and Higher Nursing, Urgench Branch of TMA, Urgench, Uzbekistan
Kilicheva T. A. Assistant of the Department of Propaedeutics of Pediatric Diseases, Urgench Branch of TMA, Urgench, Uzbekistan

Keywords:

Mitral valve dysplasia, heart, patients, drug therapy, blood pressure, extrasystole.

Abstract

Hemodynamic shifts in patients with mitral valve dysplasia (MVD) were investigated in this article. Forty-seven patients with DMC were examined. Hemodynamic changes in patients with DMC can be characterized as a risk factor for myocardial dystrophy and heart failure. It is recommended to conduct timely complex treatment with obligatory inclusion of immunomodulatory therapy in DMC patients.